Page 1302 - Saunders Comprehensive Review For NCLEX-RN
P. 1302

1. Description: The client with cancer is at increased risk
                                                for infection, particularly gram-negative organisms, in
                                                the bloodstream (sepsis or septicemia) and DIC, a life-
                                                threatening problem frequently associated with
                                                sepsis.
                                             2. Interventions
                                                             a. Prevent the complication through early
                                                                identification of clients at high risk for
                                                                sepsis and DIC.
                                                             b. Maintain strict aseptic technique with
                                                                the immunocompromised client and
                                                                monitor closely for infection and signs
                                                                of bleeding.
                                                             c. Administer antibiotics intravenously as
                                                                prescribed.
                                                             d. Administer anticoagulants as
                                                                prescribed during the early phase of
                                                                DIC.
                                                             e. Administer cryoprecipitated clotting
                                                                factors, as prescribed, when DIC
                                                                progresses and hemorrhage is the
                                                                primary problem.




                                                                       Notify the PHCP immediately if signs of an

                                                                oncological emergency occur.
                                B. Syndrome of inappropriate antidiuretic hormone (SIADH)
                                             1. Description
                                                             a. Tumors can produce, secrete, or
                                                                stimulate substances that mimic
                                                                antidiuretic hormone.
                                                             b. Mild symptoms include weakness,
                                                                muscle cramps, loss of appetite, and
                                                                fatigue; serum sodium levels range
                                                                from 115 to 120 mEq/L (115 to
                                                                120 mmol/L).
                                                             c. More serious signs and symptoms relate
                                                                to water intoxication and include
                                                                weight gain, personality changes,
                                                                confusion, and extreme muscle
                                                                weakness.
                                                             d. As the serum sodium level approaches
                                                                110 mEq/L (110 mmol/L), seizures,
                                                                coma, and eventually death will occur,
                                                                unless the condition is treated rapidly.
                                             2. Interventions
                                                             a. Initiate fluid restriction and increased




                                                         1302
   1297   1298   1299   1300   1301   1302   1303   1304   1305   1306   1307